Find Nebivolol manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

FDF DossiersDRUG PRODUCT COMPOSITIONS

184RELATED EXCIPIENT COMPANIES

306EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Exclusivities

0

Health Canada Patents

MARKET PLACE

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 169293-50-9, Nebivolol hcl, 2,2'-azanediylbis(1-(6-fluorochroman-2-yl)ethanol) hydrochloride, 152520-56-4, Rac nebivolol hydrochloride, R 065824 hydrochloride
Molecular Formula
C22H26ClF2NO4
Molecular Weight
441.9  g/mol
InChI Key
JWEXHQAEWHKGCW-UHFFFAOYSA-N

Nebivolol
A cardioselective ADRENERGIC BETA-1 RECEPTOR ANTAGONIST (beta-blocker) that functions as a VASODILATOR through the endothelial L-arginine/ NITRIC OXIDE system. It is used to manage HYPERTENSION and chronic HEART FAILURE in elderly patients.
1 2D Structure

Nebivolol

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
1-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)-2-[[2-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)-2-hydroxyethyl]amino]ethanol;hydrochloride
2.1.2 InChI
InChI=1S/C22H25F2NO4.ClH/c23-15-3-7-19-13(9-15)1-5-21(28-19)17(26)11-25-12-18(27)22-6-2-14-10-16(24)4-8-20(14)29-22;/h3-4,7-10,17-18,21-22,25-27H,1-2,5-6,11-12H2;1H
2.1.3 InChI Key
JWEXHQAEWHKGCW-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1CC2=C(C=CC(=C2)F)OC1C(CNCC(C3CCC4=C(O3)C=CC(=C4)F)O)O.Cl
2.2 Synonyms
2.2.1 MeSH Synonyms

1. 67555, R

2. Alpha,alpha'-(iminobis(methylene))bis(6-fluoro-3,4-dihydro)-2h-1-benzopyran-2-methanol

3. Bystolic

4. Hydrochloride, Nebivolol

5. Lobivon

6. Nebilet

7. Nebivolol

8. R 67555

9. R-67555

10. R67555

11. Silostar

2.2.2 Depositor-Supplied Synonyms

1. 169293-50-9

2. Nebivolol Hcl

3. 2,2'-azanediylbis(1-(6-fluorochroman-2-yl)ethanol) Hydrochloride

4. 152520-56-4

5. Rac Nebivolol Hydrochloride

6. R 065824 Hydrochloride

7. Nebilox

8. Rac-nebivolol Hcl

9. R-067555

10. Schembl514784

11. N-phenyliminodiaceticacid

12. Chembl1201731

13. Akos016006035

14. Ac-4233

15. Ac-5636

16. Ccg-214847

17. Ro67555

18. As-12100

19. Cs-0362720

20. Ft-0652243

21. Ft-0655833

22. 520n564

23. W-60374

24. J-010524

25. 1-(6-fluoro-3,4-dihydro-2h-chromen-2-yl)-2-[[2-(6-fluoro-3,4-dihydro-2h-chromen-2-yl)-2-hydroxyethyl]amino]ethanol;hydrochloride

26. 2h-1-benzopyran-2-methanol,a,a'-[iminobis(methylene)]bis[6-fluoro-3,4-dihydro-,hydrochloride(1:1)

27. Alpha,alpha'[iminobis(methylene)]bis[6-fluoro-3,4-dihydro-2h-1-benzopyran-2-methanol]hydrochloride

2.3 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 441.9 g/mol
Molecular Formula C22H26ClF2NO4
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count7
Rotatable Bond Count6
Exact Mass441.1518423 g/mol
Monoisotopic Mass441.1518423 g/mol
Topological Polar Surface Area71 Ų
Heavy Atom Count30
Formal Charge0
Complexity483
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count4
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Adrenergic beta-1 Receptor Agonists

Compounds that bind to and activate ADRENERGIC BETA-1 RECEPTORS. (See all compounds classified as Adrenergic beta-1 Receptor Agonists.)


Antihypertensive Agents

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)


Vasodilator Agents

Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)


4.2 FDA Pharmacological Classification
4.2.1 Pharmacological Classes
beta-Adrenergic Blocker [EPC]; Adrenergic beta-Antagonists [MoA]

API SUPPLIERS

read-more
read-more

01

Zeon Pharma Industries India Pvt L...

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothZeon Pharma is a manufacturer and supplier of APIs & Intermediates.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Zeon Pharma Industries India Pvt Ltd

02

Rampex Labs

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothRampex Labs – Simplifying Synthesis with Innovation, Quality, and Commitment to Global Pharmaceutical Excellence.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT arrow-down
Company Banner

03

LGM Pharma

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Flag U.S.A
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
LGM Pharma CB

04

Gonane Pharma

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGonane has API manufacturing expertise in new-age Corticosteroids, Hormones and other pharma raw materials.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Gonane Pharma

05

Jai Radhe Sales

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothJai Radhe Sales is your partner for all your sourcing needs.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Jai Radhe Sales

06

Octavius Pharma Pvt. Ltd

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothOctavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Octavius Pharma

07

Honour Lab Limited

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHonour is a leading global CDMO and specialty chemicals manufacturer with seven world-class sites delivering quality-driven solutions.

Flag India
Digital Content Digital Content
USDMF arrow-down CEP/COS JDMF EU-WCarrow-down NDC arrow-down KDMF VMF Others AUDIT arrow-down
Company Banner

08

Shamrock Pharmachemi

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTogether we can improve the quality of life

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Company Banner

09

CordenPharma

Germany

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

RDD
Not Confirmed
arrow

CordenPharma

Germany

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
RDD
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT arrow-down
blank

10

Smaart Pharmaceutticals

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

RDD
Not Confirmed
arrow

Smaart Pharmaceutticals

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
RDD
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-moreread-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHonour is a leading global CDMO and specialty chemicals manufacturer with seven world-class sites delivering quality-driven solutions.

Flag India
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2015-01-05

Pay. Date : 2014-10-07

DMF Number : 28627

Submission : 2014-09-10

Status : Active

Type : II

Company Banner

02

RDD
Not Confirmed

02

RDD
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2014-03-25

Pay. Date : 2013-09-11

DMF Number : 21152

Submission : 2007-12-08

Status : Active

Type : II

blank

03

RDD
Not Confirmed

03

RDD
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2014-10-13

Pay. Date : 2014-10-06

DMF Number : 22735

Submission : 2009-03-31

Status : Active

Type : II

blank

04

Hetero Drugs Ltd

India

USDMF

arrow
RDD
Not Confirmed

04

RDD
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2013-04-04

Pay. Date : 2012-12-05

DMF Number : 25296

Submission : 2011-09-12

Status : Active

Type : II

blank

05

RDD
Not Confirmed

06

RDD
Not Confirmed

06

RDD
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2016-10-21

Pay. Date : 2016-08-24

DMF Number : 29996

Submission : 2016-02-19

Status : Active

Type : II

blank

07

RDD
Not Confirmed

07

RDD
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2014-12-01

Pay. Date : 2014-11-20

DMF Number : 24916

Submission : 2011-05-04

Status : Active

Type : II

blank

08

RDD
Not Confirmed

08

09

RDD
Not Confirmed

10

RDD
Not Confirmed

10

RDD
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2016-04-13

Pay. Date : 2015-09-21

DMF Number : 29730

Submission : 2015-09-28

Status : Active

Type : II

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

CEP/COS

read-more
read-moreread-more

ALKEM LABORATORIES LIMITED Mumbai I...

Contact Supplier
Flag India
Virtual Booth Virtual Booth
Digital Content Digital Content
CEP 2024-481 - Rev 00
Valid
Chemical
2025-12-04
2775
blank

01

ALKEM LABORATORIES LIMITED Mumbai I...

India
RDD
Not Confirmed
arrow

ALKEM LABORATORIES LIMITED Mumbai I...

India
arrow
RDD
Not Confirmed

Certificate Number : CEP 2024-481 - Rev 00

Status : Valid

Issue Date : 2025-12-04

Type : Chemical

Substance Number : 2775

blank

02

RDD
Not Confirmed
arrow

04

RDD
Not Confirmed
arrow

05

RDD
Not Confirmed
arrow

06

RDD
Not Confirmed
arrow

08

RDD
Not Confirmed
arrow

09

RDD
Not Confirmed
arrow

10

RDD
Not Confirmed
arrow
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

EU WC

read-more
read-moreread-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHonour is a leading global CDMO and specialty chemicals manufacturer with seven world-class sites delivering quality-driven solutions.

Flag India
Digital Content Digital Content

Nebivolol Hydrochloride IH

Date of Issue : 2025-09-03

Valid Till : 2028-09-02

Written Confirmation Number : WC-0362

Address of the Firm : Plot No:4, Hetero Infrastructure SEZ Ltd.,Narasapuram, Visakhapatnam-531081, And...

Company Banner

02

RDD
Not Confirmed
arrow
arrow
RDD
Not Confirmed

Nebivolol BP/IP

Date of Issue : 2022-11-18

Valid Till : 2025-02-18

Written Confirmation Number : WC-0325

Address of the Firm : M/s. Abhilasha Pharma Pvt. Ltd, Plot No. 1408/1409, G.I.D.C, Near Buch Plastic U...

blank

03

Alkem Laboratories

India
RDD
Not Confirmed
arrow

Alkem Laboratories

India
arrow
RDD
Not Confirmed

Nebivolol Hydrochloride IH

Date of Issue : 2025-09-29

Valid Till : 2028-06-05

Written Confirmation Number : WC-0370

Address of the Firm : Plot No. 288/A, 289-290, G.I.D.C At & Post-Ankleshwar, Dist.- Bharuch, Gujarat, ...

blank

04

RDD
Not Confirmed
arrow
arrow
RDD
Not Confirmed

Nebivolol Hydrochloride IH

Date of Issue : 2025-09-03

Valid Till : 2028-09-02

Written Confirmation Number : WC-0074

Address of the Firm : 294, G.I.D.C. Estate, Ankleshwar, Dist. -Bharuch-393002, Gujarat State, India

blank

05

Hetero Drugs

India
RDD
Not Confirmed
arrow

Hetero Drugs

India
arrow
RDD
Not Confirmed

Nebivolol Hydrochloride IH/EP

Date of Issue : 2025-09-19

Valid Till : 2028-07-03

Written Confirmation Number : WC-0040

Address of the Firm : Unit-l, Sy. No. 213, 214 & 255, Bonthapally (Village),Gummadidala (Mandal), Sang...

blank

06

RDD
Not Confirmed
arrow
arrow
RDD
Not Confirmed

Nebivolol Hydrochloride IH/Ph. Eur

Date of Issue : 2025-09-08

Valid Till : 2028-08-15

Written Confirmation Number : WC-0022

Address of the Firm : Plot No. 182 to 186, 192-A and 193 to 197 & 212/A,B,C,D Phase-ll, IDA, Pashamyla...

blank

07

RDD
Not Confirmed
arrow
arrow
RDD
Not Confirmed

Nebivolol Hydrochloride Ph. Eur.

Date of Issue : 2025-09-11

Valid Till : 2028-09-10

Written Confirmation Number : WC-0166

Address of the Firm : Indrad :382721, Tal. -Kadi, District: Mehsana, Gujarat, India

blank

08

RDD
Not Confirmed
arrow
arrow
RDD
Not Confirmed

Nebivolol IH

Date of Issue : 2021-02-12

Valid Till : 2022-07-04

Written Confirmation Number : WC-0070Amended

Address of the Firm : Unit-1, 37/A, 38, 39 A&B, PHASE-1, IDA, Jeedimetla, Hyderabad, 500 055, Telangan...

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

KDMF

read-more
read-moreread-more

01

Alkem Laboratories

India
RDD
Not Confirmed
arrow

Alkem Laboratories

India
arrow
RDD
Not Confirmed

Nebivolol hydrochloride

Registrant Name : Huseong Bio Co., Ltd.

Registration Date : 2026-03-12

Registration Number : 20260312-178-I-747-07

Manufacturer Name : Alkem Laboratories Limited

Manufacturer Address : Plot No. 288/A, 289-290, GIDC, At & Post-Ankleshwar, Dist.-Bharuch, PIN 393002, Gujar...

blank

02

Hetero Drugs

India
RDD
Not Confirmed
arrow

Hetero Drugs

India
arrow
RDD
Not Confirmed

Nebivolol hydrochloride

Registrant Name : Hyundai Pharmaceutical Co., Ltd.

Registration Date : 2012-12-21

Registration Number : 20120413-178-I-94-02(2)

Manufacturer Name : Hetero Drugs Limited

Manufacturer Address : Sy.No.213.214&255, Bonthapally Village, Jinnaram Mandal, Medak District, Andhra, Prad...

blank

03

Hetero Drugs

India
RDD
Not Confirmed
arrow

Hetero Drugs

India
arrow
RDD
Not Confirmed

Nebivolol hydrochloride

Registrant Name : Youngjin Pharmaceutical Co., Ltd.

Registration Date : 2013-07-18

Registration Number : 20120413-178-I-94-02(3)

Manufacturer Name : Hetero Drugs Limited

Manufacturer Address : Sy.No.213.214&255, Bonthapally Village, Jinnaram Mandal, Medak District, Telangana, I...

blank

04

RDD
Not Confirmed
arrow
arrow
RDD
Not Confirmed

Nebivolol hydrochloride

Registrant Name : Korea Menarini Co., Ltd.

Registration Date : 2012-10-12

Registration Number : 20121012-178-I-128-03

Manufacturer Name : Janssen Pharmaceutica NV

Manufacturer Address : Jassen Pharmaceuticalaan 3 2440 Geel Belgium

blank

05

RDD
Not Confirmed
arrow
arrow
RDD
Not Confirmed

Nebivolol hydrochloride

Registrant Name : Pharmapia Co., Ltd.

Registration Date : 2025-02-12

Registration Number : 20130412-178-I-198-05(A)

Manufacturer Name : Torrent Pharmaceuticals Ltd.

Manufacturer Address : Indrad-382 721, Tal:Kadi, City:Indrad, Dist.:Mehsana, Gujarat state, India

blank

06

RDD
Not Confirmed
arrow
arrow
RDD
Not Confirmed

Nebivolol hydrochloride

Registrant Name : Chodang Pharmaceutical Co., Ltd.

Registration Date : 2013-04-12

Registration Number : 20130412-178-I-198-05

Manufacturer Name : Torrent Pharmaceuticals Limi...

Manufacturer Address : Survey No 758, Indrad, Taluka Kadi, Ahmedabad - Mehsana Highway, District Mehsana. No...

blank

07

RDD
Not Confirmed
arrow
arrow
RDD
Not Confirmed

Nebivolol hydrochloride

Registrant Name : Sangjin Trading Co., Ltd.

Registration Date : 2013-02-14

Registration Number : 20130214-178-I-80-04

Manufacturer Name : Cadila Pharmaceuticals Ltd.

Manufacturer Address : 294, GIDC Estate., Ankleshwar - 393 002, Dist: Bharuch

blank

08

RDD
Not Confirmed
arrow
arrow
RDD
Not Confirmed

Nebivolol hydrochloride

Registrant Name : Korea Menarini Co., Ltd.

Registration Date : 2018-07-21

Registration Number : 20130214-178-I-80-04(4)

Manufacturer Name : Cadila Pharmaceuticals Ltd.

Manufacturer Address : 294, GIDC Estate., Ankleshwar - 393 002, Dist: Bharuch

blank

09

RDD
Not Confirmed
arrow
arrow
RDD
Not Confirmed

Nebivolol hydrochloride

Registrant Name : Pharmapia Co., Ltd.

Registration Date : 2016-03-30

Registration Number : 20130214-178-I-80-04(1)

Manufacturer Name : Cadila Pharmaceuticals Ltd.

Manufacturer Address : 294, GIDC Estate, Ankleshwar-393 002, Dist: Bharuch

blank

10

RDD
Not Confirmed
arrow
arrow
RDD
Not Confirmed

Nebivolol hydrochloride

Registrant Name : Hiple Co., Ltd.

Registration Date : 2017-02-09

Registration Number : 20130214-178-I-80-04(2)

Manufacturer Name : Cadila Pharmaceuticals Ltd.

Manufacturer Address : 294, GIDC Estate., Ankleshwar - 393 002, Dist: Bharuch

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Drugs in Development

read-more
read-more
  • Development Update

Details:

Testosterone Enanthate is a hormone drug, which is currently being evaluated in clinical studies for the treatment of undisclosed medical condition.


Lead Product(s): Testosterone Enanthate,Testosterone Cypionate,Testosterone Propionate,Testosterone,Methenolone Enanthate,Nandrolone Decanoate,Estradiol,Progesterone

Therapeutic Area: Undisclosed Brand Name: Undisclosed

Study Phase: UndisclosedProduct Type: Hormone

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable May 06, 2026

blank

01

Enhanced Emirates Limited

Country
arrow
RDD
Not Confirmed

Enhanced Emirates Limited

Country
arrow
RDD
Not Confirmed

Details : Testosterone Enanthate is a hormone drug, which is currently being evaluated in clinical studies for the treatment of undisclosed medical condition.

Product Name : Undisclosed

Product Type : Hormone

Upfront Cash : Inapplicable

May 06, 2026

blank

Details:

Through the acquisition of Nebivolol HCl, targeting the Beta-2 adrenergic receptor, the deal aims to advance hypertension treatment.


Lead Product(s): Nebivolol,Inapplicable

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Undisclosed

Study Phase: Approved FDFProduct Type: Miscellaneous

Sponsor: Senores Pharmaceuticals

Deal Size: $1.6 million Upfront Cash: Undisclosed

Deal Type: Acquisition December 17, 2025

blank

02

Apnar Pharma

U.S.A
arrow
RDD
Not Confirmed

Apnar Pharma

U.S.A
arrow
RDD
Not Confirmed

Details : Through the acquisition of Nebivolol HCl, targeting the Beta-2 adrenergic receptor, the deal aims to advance hypertension treatment.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Undisclosed

December 17, 2025

blank

Details:

Nebivolol is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.


Lead Product(s): Nebivolol,Inapplicable

Therapeutic Area: Undisclosed Brand Name: Undisclosed

Study Phase: Phase IProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable February 08, 2024

blank

03

Bio-innova

Thailand
arrow
RDD
Not Confirmed

Bio-innova

Thailand
arrow
RDD
Not Confirmed

Details : Nebivolol is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

February 08, 2024

blank

Details:

Nebivolol is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Hypertension.


Lead Product(s): Nebivolol,Ramipril

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Undisclosed

Study Phase: Phase IVProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable October 27, 2023

blank

04

Menarini

Italy
arrow
RDD
Not Confirmed

Menarini

Italy
arrow
RDD
Not Confirmed

Details : Nebivolol is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Hypertension.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

October 27, 2023

blank

Details:

Nebivolol is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Hypertension.


Lead Product(s): Nebivolol,Amlodipine

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Undisclosed

Study Phase: Phase IVProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable August 24, 2022

blank

05

Menarini

Italy
arrow
RDD
Not Confirmed

Menarini

Italy
arrow
RDD
Not Confirmed

Details : Nebivolol is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Hypertension.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

August 24, 2022

blank

Details:

Zofenopril is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Hypertension.


Lead Product(s): Zofenopril,Nebivolol

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Undisclosed

Study Phase: Phase IVProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable February 25, 2022

blank

06

Menarini

Italy
arrow
RDD
Not Confirmed

Menarini

Italy
arrow
RDD
Not Confirmed

Details : Zofenopril is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Hypertension.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

February 25, 2022

blank

Details:

Nebivolol is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Glaucoma, Open-Angle.


Lead Product(s): Nebivolol,Inapplicable

Therapeutic Area: Ophthalmology Brand Name: Undisclosed

Study Phase: Phase IIProduct Type: Miscellaneous

Sponsor: Trial Runners, LLC | Summit Analytical LLC

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable June 02, 2021

blank

07

Betaliq

U.S.A
arrow
RDD
Not Confirmed

Betaliq

U.S.A
arrow
RDD
Not Confirmed

Lead Product(s) : Nebivolol,Inapplicable

Therapeutic Area : Ophthalmology

Highest Development Status : Phase II

Partner/Sponsor/Collaborator : Trial Runners, LLC | Summit Analytical LLC

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : Nebivolol is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Glaucoma, Open-Angle.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

June 02, 2021

blank

Details:

DWN12088 is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Idiopathic Pulmonary Fibrosis.


Lead Product(s): DWN12088,Nebivolol

Therapeutic Area: Pulmonary/Respiratory Diseases Brand Name: Undisclosed

Study Phase: Phase IProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable May 17, 2021

blank

08

RDD
Not Confirmed
RDD
Not Confirmed

Details : DWN12088 is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Idiopathic Pulmonary Fibrosis.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

May 17, 2021

blank

Details:

Nebivolol is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.


Lead Product(s): Nebivolol,Inapplicable

Therapeutic Area: Undisclosed Brand Name: Undisclosed

Study Phase: Phase IProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable May 07, 2018

blank

09

RDD
Not Confirmed
RDD
Not Confirmed

Details : Nebivolol is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

May 07, 2018

blank

Details:

Nebivolol is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.


Lead Product(s): Nebivolol,Inapplicable

Therapeutic Area: Undisclosed Brand Name: Undisclosed

Study Phase: Phase IProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable May 07, 2018

blank

10

RDD
Not Confirmed
RDD
Not Confirmed

Details : Nebivolol is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

May 07, 2018

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - TABLET;ORAL - EQ 5MG BASE;80MG

USFDA APPLICATION NUMBER - 206302

read-more

DOSAGE - TABLET;ORAL - EQ 10MG BASE

USFDA APPLICATION NUMBER - 21742

read-more

DOSAGE - TABLET;ORAL - EQ 2.5MG BASE

USFDA APPLICATION NUMBER - 21742

read-more

DOSAGE - TABLET;ORAL - EQ 20MG BASE

USFDA APPLICATION NUMBER - 21742

read-more

DOSAGE - TABLET;ORAL - EQ 5MG BASE

USFDA APPLICATION NUMBER - 21742

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Coating Systems & Additives

read-more
read-more

Direct Compression

read-more
read-more

Granulation

read-more
read-more

Controlled & Modified Release

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Lubricants & Glidants

read-more
read-more

Solubilizers

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Co-Processed Excipients

read-more
read-more

Taste Masking

read-more
read-more

Parenteral

read-more
read-more

Emulsifying Agents

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

API Stability Enhancers

read-more
read-more

Topical

read-more
read-more

Empty Capsules

read-more
read-more

Vegetarian Capsules

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Rheology Modifiers

read-more
read-more

Coloring Agents

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ANALYTICAL

Upload your methods for free, ask us

ABOUT THIS PAGE

Looking for 152520-56-4 / Nebivolol API manufacturers, exporters & distributors?

Nebivolol manufacturers, exporters & distributors 1

14

PharmaCompass offers a list of Nebivolol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Nebivolol manufacturer or Nebivolol supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Nebivolol manufacturer or Nebivolol supplier.

API | Excipient name

Nebivolol

Synonyms

169293-50-9, Nebivolol hcl, 2,2'-azanediylbis(1-(6-fluorochroman-2-yl)ethanol) hydrochloride, 152520-56-4, Rac nebivolol hydrochloride, R 065824 hydrochloride

Cas Number

152520-56-4

About Nebivolol

A cardioselective ADRENERGIC BETA-1 RECEPTOR ANTAGONIST (beta-blocker) that functions as a VASODILATOR through the endothelial L-arginine/ NITRIC OXIDE system. It is used to manage HYPERTENSION and chronic HEART FAILURE in elderly patients.

Narbivolol Manufacturers

A Narbivolol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Narbivolol, including repackagers and relabelers. The FDA regulates Narbivolol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Narbivolol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Narbivolol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

Narbivolol Suppliers

A Narbivolol supplier is an individual or a company that provides Narbivolol active pharmaceutical ingredient (API) or Narbivolol finished formulations upon request. The Narbivolol suppliers may include Narbivolol API manufacturers, exporters, distributors and traders.

click here to find a list of Narbivolol suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

Narbivolol USDMF

A Narbivolol DMF (Drug Master File) is a document detailing the whole manufacturing process of Narbivolol active pharmaceutical ingredient (API) in detail. Different forms of Narbivolol DMFs exist exist since differing nations have different regulations, such as Narbivolol USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Narbivolol DMF submitted to regulatory agencies in the US is known as a USDMF. Narbivolol USDMF includes data on Narbivolol's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Narbivolol USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Narbivolol suppliers with USDMF on PharmaCompass.

Narbivolol KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Narbivolol Drug Master File in Korea (Narbivolol KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Narbivolol. The MFDS reviews the Narbivolol KDMF as part of the drug registration process and uses the information provided in the Narbivolol KDMF to evaluate the safety and efficacy of the drug.

After submitting a Narbivolol KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Narbivolol API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Narbivolol suppliers with KDMF on PharmaCompass.

Narbivolol CEP

A Narbivolol CEP of the European Pharmacopoeia monograph is often referred to as a Narbivolol Certificate of Suitability (COS). The purpose of a Narbivolol CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Narbivolol EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Narbivolol to their clients by showing that a Narbivolol CEP has been issued for it. The manufacturer submits a Narbivolol CEP (COS) as part of the market authorization procedure, and it takes on the role of a Narbivolol CEP holder for the record. Additionally, the data presented in the Narbivolol CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Narbivolol DMF.

A Narbivolol CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Narbivolol CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of Narbivolol suppliers with CEP (COS) on PharmaCompass.

Narbivolol WC

A Narbivolol written confirmation (Narbivolol WC) is an official document issued by a regulatory agency to a Narbivolol manufacturer, verifying that the manufacturing facility of a Narbivolol active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Narbivolol APIs or Narbivolol finished pharmaceutical products to another nation, regulatory agencies frequently require a Narbivolol WC (written confirmation) as part of the regulatory process.

click here to find a list of Narbivolol suppliers with Written Confirmation (WC) on PharmaCompass.

Narbivolol NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Narbivolol as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Narbivolol API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Narbivolol as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Narbivolol and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Narbivolol NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Narbivolol suppliers with NDC on PharmaCompass.

Narbivolol GMP

Narbivolol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Narbivolol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Narbivolol GMP manufacturer or Narbivolol GMP API supplier for your needs.

Narbivolol CoA

A Narbivolol CoA (Certificate of Analysis) is a formal document that attests to Narbivolol's compliance with Narbivolol specifications and serves as a tool for batch-level quality control.

Narbivolol CoA mostly includes findings from lab analyses of a specific batch. For each Narbivolol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Narbivolol may be tested according to a variety of international standards, such as European Pharmacopoeia (Narbivolol EP), Narbivolol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Narbivolol USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty